Regenxbio Total Debt To Capitalization from 2010 to 2024

RGNX Stock  USD 10.01  0.46  4.82%   
Regenxbio Total Debt To Capitalization yearly trend continues to be fairly stable with very little volatility. Total Debt To Capitalization is likely to outpace its year average in 2024. During the period from 2010 to 2024, Regenxbio Total Debt To Capitalization regression line of annual values had significance of  0.07 and arithmetic mean of (0.25). View All Fundamentals
 
Total Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.02216994
Current Value
0.0233
Quarterly Volatility
0.53685317
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Total Debt To Capitalization Growth Pattern

Below is the plot of the Total Debt To Capitalization of Regenxbio over the last few years. It is Regenxbio's Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization10 Years Trend
Slightly volatile
   Total Debt To Capitalization   
       Timeline  

Regenxbio Total Debt To Capitalization Regression Statistics

Arithmetic Mean(0.25)
Coefficient Of Variation(216.94)
Mean Deviation0.34
Median0.01
Standard Deviation0.54
Sample Variance0.29
Range2.0671
R-Value0.48
Mean Square Error0.24
R-Squared0.23
Significance0.07
Slope0.06
Total Sum of Squares4.03

Regenxbio Total Debt To Capitalization History

2024 0.0233
2023 0.0222
2022 0.0115
2021 0.002287
2020 0.006575
2015 0.005349
2014 -2.04

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Debt To Capitalization 0.02  0.02 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.